SF-86 Drug Use: What the Form Asks, How Adjudicators Evaluate It, and What Affects the Outcome

If drug use is part of your history and the SF-86 is in front of you, the short answer is this. Past use within the form's lookback windows generally has to be reported, and it does not by itself decide the outcome. Adjudicators weigh how recent and frequent the use was, the circumstances, what has changed since, and often most of all, whether the form was answered honestly.

Many people reach this question while holding a half-finished form. Some are wondering whether a few college-era experiments still count. Others used marijuana legally under state law, or once took a friend's prescription, and are not sure where that fits. The SF-86 (the Questionnaire for National Security Positions) is the form a sponsoring agency or employer asks a person to complete once that organization has decided a position requires a background investigation. Individuals do not apply for a clearance on their own. This article walks through what the drug questions cover and how adjudication (the government's eligibility decision) treats the answers. It also covers what happens if the government raises a formal concern.

What the SF-86 Drug Use Questions Actually Ask

Section 23 of the SF-86 covers illegal use of controlled substances and drug activity. Its reach is broader than many people assume. The questions go beyond consumption to purchase, sale, manufacture and trafficking. They also cover misuse of prescription drugs, meaning use of another person's prescription or use of one's own prescription in a way the prescriber did not intend.

The lookback windows differ by question. Several ask about the past seven years. Others ask whether certain conduct has ever occurred. Use while holding a clearance or while in a sensitive position is asked about separately from earlier use, so a person who used before entering cleared work and someone who used afterward answer different questions.

Marijuana is a frequent source of confusion. For SF-86 purposes it is an illegal controlled substance under federal law, whatever state law says.

The SF-86 remains one of the standard investigative forms the Defense Counterintelligence and Security Agency (DCSA) lists for background investigations. Its planned successor is the Personnel Vetting Questionnaire (PVQ). Whether the PVQ applies to a given person depends on the agency and the timing of its rollout.

The honesty of each answer is evaluated on its own terms. A false or incomplete answer can create a problem more serious than the conduct it concerns.

Guideline H: The Adjudicative Framework for Drug Involvement

Security Executive Agent Directive 4 (SEAD 4), issued by the Director of National Intelligence, sets out the 13 adjudicative guidelines used across the federal government. Guideline H is titled "Drug Involvement and Substance Misuse." Drug-related information on an SF-86 is evaluated under it. For a closer look at the guideline itself, see our page on Guideline H drug involvement.

The concern behind Guideline H is about judgment and reliability. Illegal drug use, or misuse of prescription drugs, can raise questions about whether a person will follow rules. It can also raise questions about vulnerability to pressure or exploitation.

The conditions that may raise a concern under the guideline include:

• any drug use while holding a clearance or occupying a sensitive position
• recent or recurring illegal use
• drug-related criminal conduct, such as illegal possession or purchase
• illegal involvement in distribution or trafficking
• failure to complete a drug treatment program prescribed by a qualified professional

The guideline also lists conditions that may mitigate the concern:

• the use happened long ago, was infrequent, or arose in circumstances unlikely to recur
• the person has acknowledged the use and shown a sustained pattern of abstinence
• the person has completed treatment or counseling
• prescription misuse ended after the underlying medical situation resolved

Each condition is a factor to weigh, not a verdict. Individual agencies may apply the guideline alongside their own internal policies, so outcomes can differ between agencies.

Marijuana and Federal Law: Why State Legalization Does Not Change the Analysis

The gap between state law and federal law catches many applicants off guard. Under the Controlled Substances Act, 21 U.S.C. § 812 lists "Marihuana" and "Tetrahydrocannabinols, except for tetrahydrocannabinols in hemp" among Schedule I substances. For a substance in that schedule, the statute's findings include that it "has no currently accepted medical use in treatment in the United States." Security clearance adjudication follows federal law. A person who used marijuana legally under state law therefore still has drug use that the SF-86 asks about.

The ODNI issued guidance in 2021 on marijuana and security clearances. In substance, it said that prior marijuana use alone is not automatically disqualifying, and that recency, frequency and circumstances are part of the evaluation. Separate ODNI guidance has addressed investment in cannabis-related companies. That is a distinct question from personal use, and the details depend on the guidance currently in effect.

For marijuana in particular, recency and frequency tend to carry the most weight. A single use years before an application looks very different from ongoing use. It also looks very different from use after the person knew clearance rules applied to them. Use after submitting a clearance application, or while holding a clearance, is generally treated as more serious than earlier use.

State legality is not a defense under the federal standard. It can still be relevant context when mitigation is weighed, which is one reason accurate disclosure matters even for use that was legal locally.

How Adjudicators Evaluate Drug Use: Recency, Frequency, and the Whole-Person Standard

In practice, the guidelines are not applied mechanically. SEAD 4 directs adjudicators to apply the whole-person concept, which means weighing the entire record rather than any single fact in isolation.

The factors that commonly shape a drug use case include:

• how long ago the use occurred
• whether it was isolated or part of a pattern
• the substance involved
• the circumstances, such as experimentation versus habitual use
• whether the person held a position of trust at the time
• what the person has done since

Use while holding a clearance or in a sensitive position is among the more serious conditions. It bears directly on judgment and reliability while the person was already trusted.

Candor matters too. A person who disclosed fully on the SF-86 is often viewed differently from a person whose use came to light only through the investigation. Rehabilitation evidence can support mitigation. That evidence includes completed treatment, counseling, or a documented period of sustained abstinence. On intent not to use again, adjudicators generally look for concrete evidence, such as changed associations or environment, rather than a bare promise.

More than one guideline can be involved at once. An arrest may bring in Guideline J (Criminal Conduct). False statements on earlier forms may bring in Guideline E personal conduct. When an adjudicator proposes a denial or revocation, the person typically receives a Statement of Reasons (SOR), which names the guidelines and conditions at issue.

Disclosure, Omission, and the Separate Problem of Falsification

A drug question answered falsely can become a bigger problem than the drug use. The SF-86 is a federal form, and 18 U.S.C. § 1001 generally makes it a crime to knowingly and willfully make "any materially false, fictitious, or fraudulent statement or representation" in a matter within federal executive branch jurisdiction. The statute also covers concealing a material fact. That reference is educational. Whether any person has criminal exposure depends on specific facts.

Background investigations compare the form against the subject interview and against information developed from other sources. Inconsistencies tend to surface. A false or incomplete answer raises a separate concern under Guideline E for dishonesty or lack of candor.

Someone who disclosed drug use fully is generally better positioned than someone whose use emerged after an incomplete answer. When a person omits use and later corrects the record, adjudicators look at whether the correction was voluntary or came only after an investigator asked. An omission of use within a lookback window is not usually treated as a clerical slip. Whether the omission was deliberate often becomes a central question.

Timing adds another layer. The SF-86 is also used in reinvestigations, and cleared people may be subject to continuous vetting. An answer given years ago can be compared with later information, so a prior omission may surface long after the original form was signed.

When Drug Use History Leads to a Statement of Reasons — and What Comes Next

A Statement of Reasons is a formal notice that an adjudicator has found potentially disqualifying information and is proposing to deny or revoke eligibility. It is not a final decision. It identifies the Guideline H conditions, or conditions under other guidelines, and the facts the government relies on.

What follows depends on who the person is and which agency or system decides. A federal civilian employee, a service member, a contractor employee and an intelligence community applicant may each follow different procedures, with different deadlines and different review rights. For some categories, including many defense contractor employees, the process can include a hearing before an administrative judge of the Defense Office of Hearings and Appeals (DOHA). Others proceed through their own agency's procedures. Response deadlines are set by the applicable procedure, and they can matter a great deal. A missed deadline may affect what review remains available.

The written response is generally where mitigation evidence enters the record. That evidence can include treatment records, character references, declarations and legal argument. The record built at this stage often frames any later review. Published DOHA decisions show how Guideline H has been applied across many cases.

Review is limited for a reason. In Department of the Navy v. Egan, 484 U.S. 518 (1988), the Supreme Court held that a clearance decision is a discretionary, predictive judgment committed to the executive branch. This section describes the process generally and is not legal advice about any individual case.

What to Consider Before Submitting the SF-86 When Drug Use Is Part of Your History

The baseline is simple to state. The SF-86 is a signed federal form, and accuracy and completeness are the obligation it carries. Knowing the lookback windows before starting helps a person see which conduct falls within a question and which does not.

That line is not always obvious. Marijuana use, prescription misuse and use that occurred in a foreign country raise recurring questions about scope. For questions about the form itself, DCSA directs people to a specific contact for each category:

• military members: the security officer in their command
• federal civilians: the agency's security officer or HR representative
• DoD contractor employees: the facility security officer at the company
• other federal contractors: the agency's security officer or HR representative

Posture matters as well. A first-time applicant is in a different position from someone who has already received an SOR, or who faces reinvestigation with drug use in the record. Related concerns can also travel together, for example when debt appears alongside drug use and brings Guideline F financial considerations into the case.

Counsel in this field helps people understand the adjudicative framework, prepare SOR responses and appear at hearings. Counsel does not complete the SF-86 for anyone. Many applicants with drug use in their past never need a lawyer before submitting the form. Isolated, dated use that is fully disclosed and fits within Guideline H's mitigating conditions often may not call for counsel. Legal help tends to matter more in SOR responses and hearings. It also tends to matter more when several guidelines are involved or when earlier forms contained omissions.

Frequently asked questions

Does marijuana use disqualify you from getting a security clearance?

Not automatically. Adjudicators weigh recency, frequency and circumstances under Guideline H and the whole-person standard. Use after applying, or while holding a clearance, is generally treated more seriously than dated, isolated use. Federal law separately restricts clearances for current unlawful users of controlled substances. Marijuana remains federally controlled, so state-legal use is still reportable.

What drug questions does the SF-86 ask?

Section 23 asks about illegal use of controlled substances, prescription drug misuse, and drug activity such as purchase, sale, manufacture and trafficking. Several questions use a seven-year window, while others ask whether conduct ever occurred. Use while holding a clearance or in a sensitive position is asked about separately.

How do security clearance investigators verify drug use?

Investigators compare the SF-86 with the subject interview, interviews with references and associates, law enforcement records and any prior investigation files. Gaps between the disclosure and what the investigation finds can raise a separate personal conduct concern under Guideline E.

What is Guideline H in the security clearance adjudicative guidelines?

Guideline H is SEAD 4's "Drug Involvement and Substance Misuse" guideline, issued by the Director of National Intelligence. It describes the concern about judgment and reliability. It lists the conditions that may raise that concern and the conditions that may mitigate it.

What happens if you lie about drug use on the SF-86?

A false answer may raise a Guideline E concern for dishonesty or lack of candor, which is often weighed more heavily than the drug use itself. Knowingly and willfully false statements on federal matters can also carry potential criminal exposure under 18 U.S.C. § 1001, depending on the facts.

How to mitigate drug use on the SF-86?

Mitigation under Guideline H generally turns on recency, frequency, circumstances and concrete evidence of change. That evidence can include time without recurrence, completed counseling or treatment, changed associations, and full disclosure on the form. It is weighed across the whole record, not one factor at a time.

When will the PVQ replace the SF-86?

The timing depends on the agency. The Personnel Vetting Questionnaire is the planned successor to the SF-86, and rollout and applicability vary. A person's security officer, HR representative or facility security officer can confirm which form currently applies.

Can you get a security clearance with a past drug conviction?

Possibly. A drug-related conviction may raise concerns under Guideline H and Guideline J, but the whole-person standard still applies. Adjudicators consider the offense, how long ago it occurred, whether the sentence or program was completed, and later conduct. Agency policies can also affect how a conviction is weighed.

If You Want to Talk Through the Process

Drug use questions sit at the meeting point of several guidelines, a federal statute and procedures that change with a person's category and agency. A consultation can explain how Guideline H is generally applied and how mitigating factors are generally evaluated under SEAD 4. It can also cover what representation at the SOR and hearing stages typically involves. Not everyone needs that conversation. To learn more about how this process works and what options may be available, call Security Clearance Defense Group at 888-606-8957 for a free consultation.